A detailed history of Morgan Stanley transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 701,732 shares of ANIK stock, worth $17.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
701,732
Previous 485,093 44.66%
Holding current value
$17.8 Million
Previous $11 Million 62.15%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$21.95 - $26.42 $4.76 Million - $5.72 Million
216,639 Added 44.66%
701,732 $17.8 Million
Q4 2023

Feb 13, 2024

BUY
$18.47 - $23.3 $4.44 Million - $5.6 Million
240,291 Added 98.16%
485,093 $11 Million
Q3 2023

Nov 15, 2023

SELL
$16.98 - $26.1 $640,655 - $984,753
-37,730 Reduced 13.35%
244,802 $4.56 Million
Q2 2023

Aug 14, 2023

BUY
$25.16 - $28.86 $556,161 - $637,950
22,105 Added 8.49%
282,532 $7.34 Million
Q1 2023

May 15, 2023

BUY
$25.91 - $32.1 $1.76 Million - $2.19 Million
68,088 Added 35.4%
260,427 $7.48 Million
Q4 2022

Feb 14, 2023

SELL
$23.85 - $31.91 $12.4 Million - $16.5 Million
-518,349 Reduced 72.94%
192,339 $5.69 Million
Q3 2022

Nov 14, 2022

BUY
$21.74 - $24.68 $872,339 - $990,309
40,126 Added 5.98%
710,688 $16.9 Million
Q2 2022

Oct 27, 2022

BUY
$20.4 - $25.53 $740,866 - $927,173
36,317 Added 5.73%
670,562 $15 Million
Q2 2022

Aug 15, 2022

BUY
$20.4 - $25.53 $740,866 - $927,173
36,317 Added 5.73%
670,562 $15 Million
Q1 2022

Oct 27, 2022

SELL
$24.7 - $36.54 $897,029 - $1.33 Million
-36,317 Reduced 5.42%
634,245 $15.9 Million
Q1 2022

May 13, 2022

SELL
$24.7 - $36.54 $1.42 Million - $2.1 Million
-57,414 Reduced 8.3%
634,245 $15.9 Million
Q4 2021

Feb 14, 2022

BUY
$35.83 - $45.03 $4.51 Million - $5.67 Million
125,813 Added 22.23%
691,659 $24.8 Million
Q3 2021

Nov 15, 2021

BUY
$38.75 - $44.47 $21.9 Million - $25.2 Million
565,846 New
565,846 $24.1 Million

Others Institutions Holding ANIK

About Anika Therapeutics, Inc.


  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $370M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.